Partner, Advanced Technology Ventures
President and Director, Fred Hutchinson Cancer Research Center
Managing Director, CommonAngels
General Partner, Matrix Partners
President and CEO, MichBio
President, DTE Energy Ventures
Co-Founder and Managing Director, ARCH Venture Partners
Co-Founder and President, Institute for Systems Biology
|
|
Back in January I got an invitation out of the blue to give a 1-hour talk at the Palo Alto Research Center—the Xerox-owned lab better known as PARC. The invitation was completely open-ended. The full extent of PARC’s guidance was... Read more »
Broad startup initiatives, big acquisitions, critical data readouts, and more characterized the news flowing out of the biotech sector along the East Coast this week. Details below:
—Residents of Long Island, NY, were dismayed when Astellas Pharma shut down their local... Read more »
Selling digital images and video helped Shutterstock in New York make its mark. Now CEO and founder Jon Oringer sees potential to expand into other content and media. He spoke as part of Internet Week New York, discussing why his company... Read more »
Much of the media world makes its money by pairing merchandise with television programs and movies. Now Web-streaming service Crunchyroll has updated its platform to improve the way it sells toys and other show-related products to fans.
Kun Gao, co-founder and... Read more »
Ironwood Pharmaceuticals and NPS Pharmaceuticals have plenty in common: both won FDA approval of their first drugs in 2012, and both are trying to prove to investors that they can successfully sell them. And now, both have sought out Wall Street... Read more »
[Updated: 11:05 pm ET] Regeneron Pharmaceuticals became a breakout biotech star with a new drug for treating age-related macular degeneration, the leading cause of blindness among the elderly in the U.S. Now the Tarrytown, NY-based biotech believes it’s taken... Read more »
A bit of friendly rivalry is healthy for cities with growing technology ecosystems, but sometimes they set aside the hype and find ways to collaborate. At the onset of this week’s Internet Week New York citywide festivities, representatives from 11 cities... Read more »
What are the most powerful forces affecting innovation and the economy? That is one of the key questions facing the nation as we inch our way out of the economic mire.
Juan Enriquez may not have all the answers, but he... Read more »
David Karp’s wallet just got a lot fatter.
After a flurry of speculation over the weekend, Tumblr in New York is being acquired by Sunnyvale, CA-based Yahoo, in a deal announced early Monday at the previously reported price of $1.1 billion,... Read more »
When Astellas Pharma shuttered the labs of OSI Pharmaceuticals last week, no one felt that loss as acutely as the residents of Long Island, NY. OSI, famed for its lung cancer drug erlotinib (Tarceva), had shown that it was possible to... Read more »
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
For cities to truly thrive in this economy, fresh ideas must be cross-pollinated from beyond their borders—and New York offers its share of honey to lure in startups. This international gateway can be the place for companies to break into the... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
All eyes in the biotech world will soon turn to the American Society of Clinical Oncology’s annual meeting in Chicago, but for now, the industry keeps humming along. This week’s news was highlighted by partnerships, product launches and big name hirings—and... Read more »
After much clamor about becoming a sanctuary for startups, New York faces the “now what?” stage of its growth as a tech hub.
Plans have been laid down to fill the streets with engineers—in another decade or two. But... Read more »
In a city where people know people who know people, Richard Blakeley sits at the heart of a web that connects New York’s tech community.
That enviable position stems in part from his annual Webutante Ball. While preparing for next Thursday’s... Read more »
OSI Pharmaceuticals became the home-grown beacon of Long Island, NY’s biotech scene behind the lung cancer drug erlotinib (Tarceva), which was so successful that led Japan’s Astellas Pharma to buy the company outright in a $4 billion deal in May 2010.... Read more »
The search for potential investments has led the team at ff Venture Capital in New York into strange waters.
John Frankel, a partner with the firm, says he decided to back UniKey Technologies after hearing about its founder’s appearance last year... Read more »
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of startups he likes to get involved in, the trend toward... Read more »
President and CEO, Acorda Therapeutics
Professor of Molecular Biology, Rockefeller University
Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
Founder and Managing Partner, IA Ventures
Chair of Dept. of Genetics and Development, Columbia University
General Partner, Matrix Partners
CEO and Co-Founder, Endeavor
Dir., Mt. Sinai Institute for Genomics and Multi-Scale Biology
Managing Partner, Rho Capital Partners and Rho Ventures
Senior Managing Partner, Aisling Capital Fund
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
